Infectious Complications in Patients with Adult T-Cell Leukemia
نویسندگان
چکیده
منابع مشابه
Altered expression of cell cycle regulators in adult T-cell leukemia/lymphoma patients
Abstract Background: Adult T-cell leukemia/lymphoma (ATLL) is caused by human T-cell lymphotropic virus type-1 (HTLV-1). HTLV-1 oncogenes can induce malignancy through controlled gene expression of cell cycle checkpoints in the host cell. HTLV-I genes play a pivotal role in overriding cell cycle checkpoints and deregulate cellular division. In this study, we aimed to determine and comp...
متن کاملSpecific cutaneous manifestations in adult T cell leukemia/lymphoma
Background and aim: Adult T cell leukemia/lymphoma (ATLL) is an aggresive malignancy which may occur in human T lymphotropic virus1(HTLV1) infected persons. HTLV1 is endemic in Khorasan with prevalence of 2.3% in general population. Since specific cutaneous manifestations of lymphoma may occur in a significant number of patients, we studied ATLL patients in Mashhad.Mate...
متن کاملAbsence of FLT3 mutations in Iranian adult T-cell leukemia/lymphoma patients
Background: Adult T cell leukemia lymphoma (ATLL) is a rare disease, significantly linked to the infection by the human T-cell lymphotropic virus 1(HTLV-1). ATLL is typically preceded by decades of clinical latency during which infected cells accumulate selectable traits leading to a malignant transformation. Amongst all the HTLV-1 infected carriers only about 3-5% will develop ATLL. Despite th...
متن کاملmagnesium level in patients with adult t-cell leukemia: a case report
conclusions we observed upper limit values of the normal range for mg in the atl cases which may not be neglected from a clinical point of view. the other measurements did not show a remarkable difference with normal levels. introduction adult t‐cell leukemia (atl) is a rare neoplasm of post-thymic lymphocytes observed in only 3% - 4% of patients infected with human t-lymphotropic virus (htlv-1...
متن کاملManagement of infectious complications in patients with chronic lymphocytic leukemia.
Infections remain a major cause of morbidity and mortality in patients with chronic lymphocytic leukemia (CLL). The pathogenesis of these complications is related to immune defects inherent to the primary disease as well as to therapy-related immunosuppression. The spectrum of infections seen has evolved with the therapeutic use of purine analogs, which induce specific cellular immune defects, ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of the Japanese Association for Infectious Diseases
سال: 1992
ISSN: 1884-569X,0387-5911
DOI: 10.11150/kansenshogakuzasshi1970.66.1444